trazodone has been researched along with Central Hypothyroidism in 2 studies
Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, C | 1 |
| Yu, R | 1 |
| Lennkh, C | 1 |
| Fischer, P | 1 |
| Küfferle, B | 1 |
| Kasper, S | 1 |
2 other studies available for trazodone and Central Hypothyroidism
| Article | Year |
|---|---|
Adult-onset idiopathic isolated central hypothyroidism: a case report and literature review.
Topics: Adrenergic alpha-1 Receptor Agonists; Antidepressive Agents, Second-Generation; Depression; Female; | 2015 |
Occurrence of trazodone-induced delirium.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cerebrovascular Disorders; Deliri | 1998 |